AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 145 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $8,779 | +153.7% | 801 | 0.0% | 0.01% | +133.3% |
| Q4 2022 | $3,460 | -42.3% | 801 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $6,000 | -25.0% | 801 | 0.0% | 0.01% | -14.3% |
| Q2 2022 | $8,000 | -20.0% | 801 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $10,000 | -44.4% | 801 | 0.0% | 0.01% | +600.0% |
| Q4 2021 | $18,000 | 0.0% | 801 | 0.0% | 0.00% | -94.4% |
| Q3 2021 | $18,000 | +80.0% | 801 | 0.0% | 0.02% | +125.0% |
| Q2 2021 | $10,000 | 0.0% | 801 | 0.0% | 0.01% | -20.0% |
| Q1 2021 | $10,000 | -9.1% | 801 | 0.0% | 0.01% | +11.1% |
| Q4 2020 | $11,000 | -8.3% | 801 | 0.0% | 0.01% | -35.7% |
| Q3 2020 | $12,000 | -7.7% | 801 | 0.0% | 0.01% | -12.5% |
| Q2 2020 | $13,000 | +8.3% | 801 | 0.0% | 0.02% | +14.3% |
| Q1 2020 | $12,000 | -25.0% | 801 | 0.0% | 0.01% | -33.3% |
| Q4 2019 | $16,000 | – | 801 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 503,248 | $6,535,000 | 10.30% |
| Prosight Management, LP | 360,834 | $4,685,000 | 3.84% |
| Healthcare Value Capital, LLC | 100,000 | $1,299,000 | 2.89% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,748,208 | $22,700,000 | 2.32% |
| DG Capital Management, LLC | 591,154 | $7,676,000 | 1.83% |
| NEA Management Company, LLC | 5,172,683 | $67,193,000 | 1.51% |
| Altium Capital Management LP | 408,908 | $5,310,000 | 1.47% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 170,316 | $2,212,000 | 1.17% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 298,500 | $3,875,000 | 1.02% |
| KNOTT DAVID M | 154,840 | $2,011,000 | 0.86% |